Cargando…
A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis
BACKGROUND: This study evaluated the effectiveness and safety of grapiprant for treatment of pain in dogs with osteoarthritis (OA). HYPOTHESIS/OBJECTIVES: Grapiprant will relieve pain as measured by the owner's and veterinarian's evaluation of pain in dogs with OA. Another objective was ev...
Autores principales: | Rausch‐Derra, L., Huebner, M., Wofford, J., Rhodes, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913586/ https://www.ncbi.nlm.nih.gov/pubmed/27075237 http://dx.doi.org/10.1111/jvim.13948 |
Ejemplares similares
-
Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015) -
A Prospective, Randomized, Masked, Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite
por: Zollers, B., et al.
Publicado: (2016) -
A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
por: Gaier, Ann, et al.
Publicado: (2021) -
A blinded, placebo‐controlled study on the clinical effects of vitamin E supplementation in dogs with osteoarthritis
por: Gordon, Casey L., et al.
Publicado: (2023) -
Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis
por: Steiner, Joerg M., et al.
Publicado: (2023)